The microRNAs (miRNAs) are an extensive class of small noncoding RNAs, 18 to 25 nucleotides in length, with the role of regulating gene expression through translational repression by base-pairing with partially complementary mRNAs.1) Currently, more than 3000 miRNAs have been annotated from a wide range of organisms including plants, worms, flies, mammals, and viruses. 2,3) The expression of miRNAs is regulated developmentally and spatially, and is involved in cell differentiation, proliferation, and death.
2)Recently several reports have indicated the involvement of miRNAs in human cancer and further that miRNAs might be used in future therapeutic and diagnostic applications.4) Especially, the expression level of let-7 miRNA was reduced in human lung cancer, 5) and it was shown to be the anticancer miRNA that represses RAS and/or c-MYC expression at the translational level.6) On the other hand, it has been established that genetic aberration of RAS and over-expression of c-myc are frequently involved in colon cancer. 7-9) Such findings led us to speculate that let-7 may also be reduced in its expression in colon cancer cells.In the current study, we focused on the expression of let-7 miRNA in colon cancer and its expression profile. Our functional analysis indicates that let-7 may function as one of the growth suppressive miRNAs in human colon cancer cells.
MATERIALS AND METHODS
Patients and Tissue PreparationAll human tissue samples were specimens from patients who had undergone biopsy for histological diagnosis of colon cancer at Saiseikai Ibaraki hospital, Ibaraki, Osaka, between 2000 and 2003. Informed consent in writing was obtained from each patient. The tumor and its adjacent normal tissues were also obtained. Each specimen was divided into 2 parts. One of them was subjected to Western blot analysis, and the other was used for extraction of RNA and DNA.Cell Culture and Cell Viability Human malignant cell lines SW480, DLD-1, and COLO101 (colon cancer); HL60 (myeloid leukemia); U937 (monocytic leukemia); Jurkat (Tcell leukemia); PC3 and LNCaP (prostate cancer); SH-SY5Y (neuroblastoma); HeLa (cervical cancer); and HuH7 (hepatic cancer) were grown in RPMI-1640 medium supplemented with 10% (v/v) heat-inactivated FBS (Sigma, St. Louis, MO, U.S.A.) and 2 mM L-glutamine under an atmosphere of 95% air and 5% CO 2 at 37°C. The number of viable cells was determined by the trypan-blue dye exclusion test. Plating efficiencies (the average number of colonies per 60-mm dish divided by the number of cells seeded per dish (ϫ100) were determined 14 d following inoculation of 1000 cells. The ability of the cells to grow as colonies in or on the soft agar was assessed. Briefly, 10 3 individual trypsinized cells were suspended in 5 ml RPMI 1640 medium/10% FBS/0.35% liquid Bacto-agar (Difco Laboratories. Inc.) at 40°C, immediately poured onto a 4-ml basal layer of 0.5% Bactoagar/RPMI 1640 medium/10% FBS in a 60-mm dish, and incubated at 37.5°C. The dishes were examined for the presence of colonies growing in the 0.35% agar ...